Abstract:Jingmei Huang, 1, &ast Lianshan Guo, 1, &ast Xiaoxiao Huang, 1 Xiaoping Yu, 2 Liqiao Lin, 1 Xinlin Jiang, 3 Zhihao Bai, 4 Zhengzhao Li 1 1 Department of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China; 2 Department of Radiology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China; 3 Department of General Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China; 4 College of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhengzhao Li, Department of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China, Email Zhihao Bai, College of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, People's Republic of China, Email Purpose: The study aimed to address the non-specific toxicity of cytotoxins (CTX) in liver cancer treatment and explore their combined application with the photosensitizer Ce6, co-loaded into carbonized Zn/Co bimetallic organic frameworks. The goal was to achieve controlled CTX release and synergistic photodynamic therapy, with a focus on evaluating anti-tumor activity against human liver cancer cell lines (Hep G2). Methods: Purified cobra cytotoxin (CTX) and photosensitizer Ce6 were co-loaded into carbonized Zn/Co bimetallic organic frameworks, resulting in RGD-PDA@C-ZIF@(CTX+Ce6). The formulation was designed with surface-functionalization using polydopamine and tumor-penetrating peptide RGD. This approach aimed to facilitate controlled CTX release and enhance the synergistic effect of photodynamic therapy. The accumulation of RGD-PDA@C-ZIF@(CTX+Ce6) at tumor sites was achieved through RGD's active targeting and the enhanced permeability and retention (EPR) effect. In the acidic tumor microenvironment, the porous structure of the metal-organic framework disintegrated, releasing CTX and Ce6 into tumor cells. Results: Experiments demonstrated that RGD-PDA@C-ZIF@(CTX+Ce6) nanoparticles, combined with near-infrared laser irradiation, exhibited optimal anti-tumor effects against human liver cancer cells. The formulation showcased heightened anti-tumor activity without discernible systemic toxicity. Conclusion: The study underscores the potential of utilizing metal-organic frameworks as an efficient nanoplatform for co-loading cytotoxins and photodynamic therapy in liver cancer treatment. The developed formulation, RGD-PDA@C-ZIF@(CTX+Ce6), offers a promising avenue for advancing the clinical application of cytotoxins in oncology, providing a solid theoretical foundation for future research and development. Keywords: metal-organic frameworks, cytotoxins, photodynamic therapy, liver cancer Liver cancer stands as one of the most prevalent and lethal malignancies globally. As per 2020 statistics, it ranks sixth worldwide, asserting its place among the most common cancer types and holds the third position in cancer-related mortality. 1 The carcinoma's highly invasive nature, coupled with an absence of early discernible symptoms, renders early diagnosis and intervention profoundly challenging. While conventional oncological treatments have seen some advancements, the therapeutic outcomes for liver cancer, hindered by tumor heterogeneity and drug resistance, remain suboptimal. 2,3 Thus, there's an urgent call to pioneer novel therapeutic strategies to enhance the survival rates and quality of life for patients afflicted with this condition. Nanomedicine, as an emergent therapeutic strategy, has garnered considerable attention in the realm of oncology in recent years. The distinct properties of nanomaterials position them as promising vectors capable of concurrently ferrying multiple therapeutic agents, orchestrating a multifaceted assault on tumors. 4–6 The Zn/Co metal-organic frameworks represent a class of nanomaterials endowed with exceptional modularity and multifunctionality. Their expansive surface area and porous architecture offer an optimal platform for combinatorial drug therapy. These frameworks adeptly adsorb and accommodate various drug molecules, ensuring precise drug deployment within the acidic milieu of tumor environments. 7 Cobratoxin (CTX) is an alkaline cationic polypeptide, isolated from cobra venom, spanning 60–63 amino acids and possessing a molecular weight between 6–7 -Abstract Truncated-

Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer

Cancer Cell Membrane-Camouflaged MOF Nanoparticles for a Potent Dihydroartemisinin-Based Hepatocellular Carcinoma Therapy

Programmed Release of Dihydroartemisinin for Synergistic Cancer Therapy Using a CaCO3 Mineralized Metal–Organic Framework

Bioinspired Microenvironment Responsive Nanoprodrug as an Efficient Hydrophobic Drug Self-Delivery System for Cancer Therapy

Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production

Smart Nanoplatform with Programmed Release of Dihydroartemisinin and Fe 2+ Self-Supply for Synergistic Cancer Therapy

Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors

Magnetically guided delivery of DHA and Fe ions for enhanced cancer therapy based on pH-responsive degradation of DHA-loaded Fe3O4@ C@ MIL-100 (Fe) nanoparticles

A pH-Responsive Drug-Delivery System Based on Apatinib-Loaded Metal-Organic Frameworks for Ferroptosis-Targeted Synergistic Anti-Tumor Therapy

Magnetically Guided Delivery of DHA and Fe Ions for Enhanced Cancer Therapy Based on Ph-Responsive Degradation of DHA-loaded Fe 3 O 4 @C@mil-100(Fe) Nanoparticles

Acidity-Triggered Charge-Convertible Conjugated Polymer for Dihydroartemisinin Delivery and Tumor-Specific Chemo-Photothermal Therapy.

Acid‐Degradable Hydrogen‐Generating Metal‐Organic Framework for Overcoming Cancer Resistance/Metastasis and Off‐Target Side Effects

Biomimetic Nucleation of Metal–Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core–Shell-Structured pH-Responsive Anticancer Drug Carriers

A gold cluster fused manganese dioxide nanocube loaded with dihydroartemisinin for effective cancer treatment via amplified oxidative stress

Multimodal Imaging-Guided Synergistic Photodynamic Therapy Using Carbonized Zn/Co Metal-Organic Framework Loaded with Cytotoxin Against Liver Cancer

Biodegradable Iron-Coordinated Hollow Polydopamine Nanospheres For Dihydroartemisinin Delivery And Selectively Enhanced Therapy In Tumor Cells

Erythrocyte Membrane Camouflaged Metal–Organic Framework Nanodrugs for Remodeled Tumor Microenvironment and Enhanced Tumor Chemotherapy

A Ph-Responsive Cluster Metal-Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect

Microfluidic-Assisted ZIF-Silk-Polydopamine Nanoparticles as Promising Drug Carriers for Breast Cancer Therapy

Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for Ph and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.

Highly Efficient Encapsulation of Doxorubicin Hydrochloride in Metal-Organic Frameworks for Synergistic Chemotherapy and Chemodynamic Therapy